Comparison of methods for cancer stem cell detection in prognosis of early stages NSCLC.
Boutaîna ChandouriThomas NavesMay YassineLéa IkhlefJérémy TricardAlain ChaunavelZeinab HomayedJulie PannequinNicolas GirardStéphanie DurandVincent CarréFabrice LallouéPublished in: British journal of cancer (2024)
The MIX could be more relevant for detecting and sorting CSCs than CD133. Moreover, its prognosis value could enable clinicians to better classify early-stage patients at high risk of relapse in order to tailor therapeutic decisions.